<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药合作投融资联盟 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-14T16:52:25+08:00</updated>
  <subtitle>医药行业</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>B轮融资1.55亿美元，加速IDO和PD-L1癌症疫苗临床试验</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/xfcheGEk4RFO5C0pLcMywA</id>
    <link href="https://mp.weixin.qq.com/s/xfcheGEk4RFO5C0pLcMywA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Taiho和Astex与MSD扩展肿瘤战略合作，授予SHP2新药独家许可</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/wGdlWeKwjH8GDoQe89uR8Q</id>
    <link href="https://mp.weixin.qq.com/s/wGdlWeKwjH8GDoQe89uR8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>合资新锐！一个AI驱动的药物发现企业正式成立</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/SJzIQnSQb0YvH04a-lXwww</id>
    <link href="https://mp.weixin.qq.com/s/SJzIQnSQb0YvH04a-lXwww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|Flagship正式推出Inzen公司Thanokine Biology平台开发新药</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/NE1TCFecw60husD3amOw9w</id>
    <link href="https://mp.weixin.qq.com/s/NE1TCFecw60husD3amOw9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BD交易|Amgen与EVOQ达成2.4亿美元新一代自免新药开发合作协议</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/Enhf1re8JeDHB4imqTIKgw</id>
    <link href="https://mp.weixin.qq.com/s/Enhf1re8JeDHB4imqTIKgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田宣布和KSQ达成多款T细胞和NK细胞肿瘤免疫疗法战略合作</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/Ykhx-AgsDt5r-7J26MJDQg</id>
    <link href="https://mp.weixin.qq.com/s/Ykhx-AgsDt5r-7J26MJDQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>14.5亿美元收购Kymab后，赛诺菲再花超10亿美元获得一款ILT2抗体</title>
    <updated>2021-01-13T11:13:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/W2DYqoWEVPeAADCkkS6l3w</id>
    <link href="https://mp.weixin.qq.com/s/W2DYqoWEVPeAADCkkS6l3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>技术变革！Flagship孵化基因书写公司Tessera完成2.3亿美元融资！</title>
    <updated>2021-01-13T11:13:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/McrthyppM2ixCK7lCAeLWA</id>
    <link href="https://mp.weixin.qq.com/s/McrthyppM2ixCK7lCAeLWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>7.83亿港元！欧康维视完成战略配售，加速商业化营销网络</title>
    <updated>2021-01-13T11:13:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/1a1OcXl4htVYw7fK2Vsa3g</id>
    <link href="https://mp.weixin.qq.com/s/1a1OcXl4htVYw7fK2Vsa3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>微生物组新药公司Vedanta Biosciences获得辉瑞2500万美元投资</title>
    <updated>2021-01-13T11:13:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/_2HISURKeXBbBDYC5b30Yw</id>
    <link href="https://mp.weixin.qq.com/s/_2HISURKeXBbBDYC5b30Yw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDC新药平台公司完成4400万美元A1轮融资，华人参与创立</title>
    <updated>2021-01-13T11:13:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/ucz4f4xwFy5L60he221vWQ</id>
    <link href="https://mp.weixin.qq.com/s/ucz4f4xwFy5L60he221vWQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BD交易|永泰生物1200万美元引进一款肾癌TCR免疫疗法</title>
    <updated>2021-01-13T11:13:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/AncB2pFc6iqWJRBKhkA0BQ</id>
    <link href="https://mp.weixin.qq.com/s/AncB2pFc6iqWJRBKhkA0BQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>超25亿美元，百济神州又做了两个交易引爆2021年交易大年！</title>
    <updated>2021-01-12T11:02:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/nQc8XSzy-FD7oYBn30JkAw</id>
    <link href="https://mp.weixin.qq.com/s/nQc8XSzy-FD7oYBn30JkAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>B轮融资1.9亿美元，David Berry创办的AI新药平台公布在研项目</title>
    <updated>2021-01-12T11:02:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/ocbePBUUcMiE4MYPm0xSFQ</id>
    <link href="https://mp.weixin.qq.com/s/ocbePBUUcMiE4MYPm0xSFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！5亿美元B轮融资，基石药业海外合作伙伴EQRx加速产品开发</title>
    <updated>2021-01-12T11:02:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/d6efKjcTcT0q5c9auj4vJw</id>
    <link href="https://mp.weixin.qq.com/s/d6efKjcTcT0q5c9auj4vJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Immunocore宣布完成7500万美元C轮融资</title>
    <updated>2021-01-12T11:02:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/qSizLI3cOB3fdHsEbs44wA</id>
    <link href="https://mp.weixin.qq.com/s/qSizLI3cOB3fdHsEbs44wA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>神经退行性疾病的先驱RNAi疗法获1.1亿美元启动，诺奖得主参与</title>
    <updated>2021-01-12T11:02:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/7VGrwuvdK2SJtK6EG5Hzrg</id>
    <link href="https://mp.weixin.qq.com/s/7VGrwuvdK2SJtK6EG5Hzrg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>3000万美元融资，推进肿瘤治疗和专有ImmunoPhage平台临床开发</title>
    <updated>2021-01-12T11:02:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/WeX2lZ9H_vBXahSARcX_CQ</id>
    <link href="https://mp.weixin.qq.com/s/WeX2lZ9H_vBXahSARcX_CQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>与礼来达成3亿美元合作，金属酶化学平台新锐完成种子轮融资</title>
    <updated>2021-01-11T13:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/hjS0gd5rxxTDZnU2I2PNQg</id>
    <link href="https://mp.weixin.qq.com/s/hjS0gd5rxxTDZnU2I2PNQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|A轮融资4000万美元，开发高度差异化IL-2抗体</title>
    <updated>2021-01-11T13:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/-jaP5zluJJmLaNR3rg8NPw</id>
    <link href="https://mp.weixin.qq.com/s/-jaP5zluJJmLaNR3rg8NPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>